Katy Barglow
Chief Technical Officer at 4D Molecular Therapeutics
- Role
- Chief Technical Officer at 4D Molecular Therapeutics
- Location
- Walnut Creek, CA, US
- LinkedIn followers
- 500 followers
About Katy Barglow
CMC leader in the gene therapy space, leading process development, clinical manufacturing, analytical development, and QC functions. I am currently Sr Vice President, Technical Operations, for 4D Molecular Therapeutics, a novel AAV gene therapy company. I am responsible for driving our \"IND engine\" and CMC strategy (process, analytical, and CMC-quality/regulatory) for pre-clinical and clinical AAV products.Skills: Process development (Biologics and gene therapy vectors), process transfers and CMO management, assay development/qualification/validation, IND-enabling characterization strategy, real-time and accelerated stability studies, QC assay transfers, IND Module 3 and CMC regulatory strategy, OOS and DR investigations.
Experience
Chief Technical Officer
Jan 2026 — Present
Education
University of California, Berkeley
Postdoctoral Fellow
2008 — 2011
Scripps Research
Doctor of Philosophy (PhD), Biochemistry
2002 — 2008
Stanford University
B.S, Chemistry
1998 — 2002
Skills
- Molecular Biology
- Hplc
- Proteomics
- Mass Spectrometry
- Cell Signaling
- Biochemistry
- Assay Development
- Cell Culture
- Cell
- Protein Purification
- Protein Chemistry
- Western Blotting
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.